IgA nephropathy trials in Slovenia

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

  Where

  Ljubljana, Maribor

  Age

  18 years and over

  People

  347 worldwide

  Run by

  Takeda

  See details and how to joinNCT06963827 · EU 2025-520825-19-00
• Phase 3Taking people
  A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  Where

  Ljubljana

  Age

  18 years to 100 years

  People

  540 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT04557462 · EU 2023-508690-92-00